ABCB1 and brain cancer: While many anticancer drugs show promising effects against different brain cancer cell lines in vitro, their efficacy in vivo and in clinical trials has been marginal at best, in large part due to ABCB1/ABCG2-mediated efflux at the blood-brain barrier.